Tanner Pharma Group to Attend Upcoming CPHI Worldwide Conference
Charlotte, NC, October 21, 2017 --(PR.com)-- Top executives from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend the CPhI Worldwide event on October 24 – 26 in Messe Frankfurt, Germany.
Tanner Pharma leverages more than 15 years of pharma services experience to provide regulatory compliance and logistical efficiency, all within an EU-GDP compliant supply chain. The company provides services through four complimentary divisions located in the U.S. and U.K.; TannerCTS, clinical trial services; TannerLAC, licensing, acquisition and commercialization; TannerGAP, global access programs; and TannerMAP, managed access programs.
Tanner Pharma representatives will include Richard Lambie, Global Director of Clinical Trial Sourcing for TannerCTS, Jonathan Bracey, Managing Director UK - SVP of Corporate Development, and Joanne Stannard, Project Manager for TannerCTS.
Individuals who wish to schedule a meeting with representatives from Tanner Pharma may contact:
United Kingdom: Ancilla Andrew | aandrew@tannerpharma.com | +44 (0) 20 3940 8111
United States: Brittney Romero | bromero@tannerpharma.com | +1 704 552 8408
About Tanner Pharma Group
For over 15 years, Tanner Pharma Group has partnered with biopharmaceutical companies to provide turn-key commercialization solutions that increase patient access to medicines around the world. We believe that access to medicines should have no borders and measure our value as a company based on the lives we help to improve. With an unparalleled blend of local market knowledge, international supply chain expertise across more than 130 countries, and high regulatory compliance and quality standards, we provide tailored solutions to biopharmaceutical companies outside their core markets of focus.
For more information about Tanner Pharma Group, please visit www.tannerpharma.com.
Tanner Pharma leverages more than 15 years of pharma services experience to provide regulatory compliance and logistical efficiency, all within an EU-GDP compliant supply chain. The company provides services through four complimentary divisions located in the U.S. and U.K.; TannerCTS, clinical trial services; TannerLAC, licensing, acquisition and commercialization; TannerGAP, global access programs; and TannerMAP, managed access programs.
Tanner Pharma representatives will include Richard Lambie, Global Director of Clinical Trial Sourcing for TannerCTS, Jonathan Bracey, Managing Director UK - SVP of Corporate Development, and Joanne Stannard, Project Manager for TannerCTS.
Individuals who wish to schedule a meeting with representatives from Tanner Pharma may contact:
United Kingdom: Ancilla Andrew | aandrew@tannerpharma.com | +44 (0) 20 3940 8111
United States: Brittney Romero | bromero@tannerpharma.com | +1 704 552 8408
About Tanner Pharma Group
For over 15 years, Tanner Pharma Group has partnered with biopharmaceutical companies to provide turn-key commercialization solutions that increase patient access to medicines around the world. We believe that access to medicines should have no borders and measure our value as a company based on the lives we help to improve. With an unparalleled blend of local market knowledge, international supply chain expertise across more than 130 countries, and high regulatory compliance and quality standards, we provide tailored solutions to biopharmaceutical companies outside their core markets of focus.
For more information about Tanner Pharma Group, please visit www.tannerpharma.com.
Contact
Tanner Pharma Group
Lindsey Stevens
704-552-8407
http://www.tannerpharma.com/
Lindsey Stevens
704-552-8407
http://www.tannerpharma.com/
Contact
Categories